PKM and hepatocellular carcinoma: Enhanced expression of PKM2 has been reported in multiple cancers including gastric cancers [5, 6], hepatocellular carcinoma [7], esophageal squamous cell carcinoma [8, 9], colorectal cancer [10], and gallbladder cancer [11].